The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 05, 2017

Filed:

Feb. 26, 2016
Applicant:

Biocardia, Inc., San Carlos, CA (US);

Inventors:

Didier Rouy, San Carlos, CA (US);

Peter A. Atlman, Menlo Park, CA (US);

Benjamin Koziner, Buenos Aires, AR;

Assignee:

BioCardia, Inc., San Carlos, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/0775 (2010.01); A61K 35/00 (2006.01); A61K 35/10 (2015.01); A61K 9/00 (2006.01); A61K 35/28 (2015.01); A61K 35/12 (2015.01); C12Q 1/68 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0663 (2013.01); A61K 9/0019 (2013.01); A61K 35/00 (2013.01); A61K 35/10 (2013.01); A61K 35/28 (2013.01); A61K 2035/124 (2013.01); C12N 2500/84 (2013.01); C12N 2502/11 (2013.01); C12Q 1/6883 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01);
Abstract

A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium which can be used in a clinical setting, and a business method for performing such expansions in the future as a service for patients. A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium including a diagnostic kit for the autologous cell therapy to determine whether a patient will respond to the autologous cell therapy for treatment of a disease, in which said kit comprising a system for detecting gene and protein expression comprising at least two isolated DNA molecules wherein each isolated DNA molecule detects expression of a gene that is differentially expressed in the tissue of the patient that is intended to be the source of the autologous cell therapy.


Find Patent Forward Citations

Loading…